[go: up one dir, main page]

IL198688A - Compounds with regulated components - Google Patents

Compounds with regulated components

Info

Publication number
IL198688A
IL198688A IL198688A IL19868809A IL198688A IL 198688 A IL198688 A IL 198688A IL 198688 A IL198688 A IL 198688A IL 19868809 A IL19868809 A IL 19868809A IL 198688 A IL198688 A IL 198688A
Authority
IL
Israel
Prior art keywords
composition
modulating agents
modulating
agents
Prior art date
Application number
IL198688A
Other languages
English (en)
Hebrew (he)
Other versions
IL198688A0 (en
Original Assignee
Foamix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foamix Pharmaceuticals Ltd filed Critical Foamix Pharmaceuticals Ltd
Publication of IL198688A0 publication Critical patent/IL198688A0/en
Publication of IL198688A publication Critical patent/IL198688A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
IL198688A 2006-11-29 2009-05-11 Compounds with regulated components IL198688A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86162006P 2006-11-29 2006-11-29
PCT/IB2007/004628 WO2008152444A2 (fr) 2006-11-29 2007-11-29 Compositions comportant des agents de modulation

Publications (2)

Publication Number Publication Date
IL198688A0 IL198688A0 (en) 2010-02-17
IL198688A true IL198688A (en) 2015-06-30

Family

ID=40130252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL198688A IL198688A (en) 2006-11-29 2009-05-11 Compounds with regulated components

Country Status (4)

Country Link
EP (1) EP2097065A2 (fr)
AU (1) AU2007355106A1 (fr)
IL (1) IL198688A (fr)
WO (1) WO2008152444A2 (fr)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
AR042906A1 (es) 2003-01-24 2005-07-06 Connetics Australia Pty Ltd Espuma de fosfato de clindamicina sensible a la temperatura y metodo de tratamiento de acne que la utiliza
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
ES2326387T3 (es) 2005-03-24 2009-10-08 Nolabs Ab Tratamiento cosmetico con oxido nitrico, dispositivo para llevar a cabo dicho tratamiento y procedimiento de fabricacion del mismo.
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
WO2009090558A2 (fr) 2008-01-14 2009-07-23 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamère avec des agents actifs et/ou des cellules thérapeutiques, et utilisations
US8637577B2 (en) 2009-01-22 2014-01-28 Absorption Pharmaceuticals, LLC Desensitizing drug product
KR101725196B1 (ko) 2009-02-25 2017-04-10 스티펠 리서치 오스트레일리아 피티와이 리미티드 국소 폼 조성물
CA2760186C (fr) 2009-04-28 2019-10-29 Foamix Ltd. Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
BRPI1014488A2 (pt) * 2009-05-15 2016-04-05 Biocepta Corp composições adequadas para o tratamento tópico de infecções fúngicas da pele e das unhas
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
CA3062005C (fr) 2009-08-21 2022-02-15 Novan, Inc. Gels topiques renfermant de l'oxyde nitrique liberant des macromoleculesde polysiloxanegels leurs utilisations
CN102686205A (zh) * 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011121062A1 (fr) 2010-03-31 2011-10-06 Helmut Vockner Composition pour le traitement de la parodontite et d'autres maladies infectieuses inflammatoires
WO2011133217A1 (fr) * 2010-04-21 2011-10-27 Pharmacline, Llc Système d'administration de médicament par voie topique avec excipients doubles
SI2579852T1 (sl) * 2010-06-11 2015-03-31 Leo Pharma A/S Farmacevtski sprej sestavek obsegajoäś vitamin d analog in kortikosteroid
US8357422B2 (en) 2010-07-02 2013-01-22 Rbc Life Sciences, Inc. Dietary supplement
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
RU2734128C2 (ru) * 2010-12-16 2020-10-13 Плэтформ Брайтворкс Ту,Лтд Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
ES2535827T3 (es) * 2011-02-11 2015-05-18 Moberg Pharma Ab Nueva composición antifúngica
CN103635179B (zh) 2011-04-28 2017-12-29 普拉福姆五金器具第二有限公司 亲脂性药剂的改进的胃肠外制剂以及制备和使用其的方法
WO2013006613A1 (fr) 2011-07-05 2013-01-10 Novan, Inc. Procédés de fabrication de compositions topiques et appareil afférent
JP6277124B2 (ja) 2011-07-05 2018-02-07 ノヴァン,インコーポレイテッド 局所用組成物
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
AU2013232576B2 (en) 2012-03-14 2016-09-01 Ligand Pharmaceuticals Incorporated Nitric oxide releasing pharmaceutical compositions
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
TW201410244A (zh) * 2012-08-13 2014-03-16 Teva Pharma 用於治療gaba媒介之疾病之拉喹莫德(laquinimod)
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
ES2836132T3 (es) 2013-08-08 2021-06-24 Novan Inc Composiciones tópicas y métodos de uso de las mismas
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
ES2759224T3 (es) * 2014-06-12 2020-05-08 Ceva Sante Animale Composiciones de feromonas de espuma compuesta
KR102495101B1 (ko) 2014-07-11 2023-02-02 노반, 인크. 국소 항바이러스 조성물 및 그의 사용 방법
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (fr) 2014-07-14 2016-01-21 Novan, Inc. Compositions de revêtement pour les ongles libérant de l'oxyde nitrique, des revêtements d'ongles libérant de l'oxyde nitrique, et leurs procédés d'utilisation
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
CN105813617B (zh) 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
CA3012227C (fr) 2015-01-23 2023-05-23 Biocidium Biopharmaceuticals Inc. Compositions anti-bacteriennes
RS60672B1 (sr) 2015-06-18 2020-09-30 Bausch Health Ireland Ltd Topikalne kompozicije koje sadrže kortikosteroide i retinoid za lečenje psorijaze
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017019614A1 (fr) 2015-07-28 2017-02-02 Novan, Inc. Associations et méthodes de traitement et/ou de prévention d'infections fongiques
BR112018009010B1 (pt) 2015-11-03 2023-09-26 Zoetis Services Llc Uso de um compósito polimérico de sol-gel para prevenir ou tratar mastite em um mamífero não humano fêmea que tem um período de lactação e sistema para formar uma barreira física no canal ou cisterna da teta do dito mamífero
CN105424884B (zh) * 2015-11-18 2017-04-05 中国海洋石油总公司 一种聚‑表二元复合驱油体系组分浓度的检测方法
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン,インコーポレイテッド 炎症のための治療用組成物およびその治療方法
WO2017173044A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
JP6899845B2 (ja) 2016-04-13 2021-07-07 ノヴァン,インコーポレイテッド 感染症を治療するための組成物、システム、キットおよび方法
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
CA2978573A1 (fr) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions et methodes de traitement de la rosacee et de l'acnee
US20180103681A1 (en) * 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for increasing stability of the pre-vapor formulation of an e-vaping device
US20180103680A1 (en) * 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for improving stability of the pre-vapor formulation of an e-vaping device
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
WO2019169221A1 (fr) 2018-03-01 2019-09-06 Novan, Inc. Suppositoires libérant de l'oxyde nitrique et leurs procédés d'utilisation
WO2019175290A1 (fr) 2018-03-13 2019-09-19 Beckley Canopy Therapeutics Limited Cannabis ou compositions dérivées du cannabis pour favoriser l'arrêt de la dépendance chimique
CN108949296B (zh) * 2018-08-15 2021-11-05 江苏四新界面剂科技有限公司 单晶硅切割表面活性剂
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
WO2020089467A1 (fr) 2018-11-02 2020-05-07 UNION therapeutics A/S Régime posologique
CA3118172A1 (fr) 2018-11-02 2020-05-07 UNION therapeutics A/S Salicylanilides halogenes pour le traitement des symptomes de dermatite
WO2021187593A1 (fr) * 2020-03-19 2021-09-23 シオノギヘルスケア株式会社 Composition contenant du valérate de bétaméthasone
DE102022116721A1 (de) 2022-07-05 2024-01-11 Paul Hartmann Ag Absorbierender Inkontinenzartikel als wegwerfbares Einmalprodukt und Verfahren zur Herstellung des Inkontinenzartikels
CN119367276B (zh) * 2024-11-01 2025-08-19 重庆金佛山高等研究院 一种抗过敏膏体及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL270627A (fr) * 1960-10-26
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
SE9000485D0 (sv) * 1990-02-09 1990-02-09 Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
WO2008075207A2 (fr) * 2006-04-04 2008-06-26 Foamix Ltd. Composition expansible d'augmentation anti-infectieuse, et kits et utilisations de celle-ci

Also Published As

Publication number Publication date
EP2097065A2 (fr) 2009-09-09
WO2008152444A2 (fr) 2008-12-18
WO2008152444A3 (fr) 2009-06-18
AU2007355106A1 (en) 2008-12-18
IL198688A0 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
IL198688A0 (en) Composition with modulating agents
GB0612803D0 (en) Polymeric composition
IL202487A0 (en) Contrast agents
IL198651A0 (en) COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL
GB0625586D0 (en) Composition
GB0607605D0 (en) Composition
EP2059135A4 (fr) Nouvelle composition
GB0623619D0 (en) Composition
GB0625429D0 (en) Composition
GB0625430D0 (en) Composition
GB0623618D0 (en) Composition
GB0625841D0 (en) Composition
PL379856A1 (pl) Kompozycja fotopolimeryzująca
GB0620338D0 (en) Composition
GB0620435D0 (en) Composition
GB0607174D0 (en) Composition
GB0605984D0 (en) Composition
GB0607823D0 (en) Composition
GB0608658D0 (en) Composition
GB0620951D0 (en) Composition
GB0604896D0 (en) Composition
GB0602260D0 (en) Composition
GB0603408D0 (en) Composition
GB0602185D0 (en) Composition
GB0612924D0 (en) Composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees